Condition
Melatonin
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 7 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
7 shownCardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving DoxorubicinNCT07349459 · 2026-04-30
COMPLETEDEfficacy of Melatonin in the Treatment of Diabetic Nephropathy Compared With Folic AcidNCT07825961 · 2025-04-01
COMPLETEDEffects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease SpectrumNCT06756828 · 2025-01-15
NOT_YET_RECRUITINGMelatonin Effects on the Left Ventricular Function in Neonates With Persistent Pulmonary HypertensionNCT07090720 · 2023-01-01
COMPLETEDEffects of Melatonin Supplementation on Sleep Quality in Patients With Advanced GlaucomaNCT06868745 · 2022-05-04
COMPLETEDMelatonin Supports Non Surgical Periodontal Treatment in Patients With Type 2 Diabetes and PeriodontitisNCT05870358 · 2021-02-18
COMPLETEDDiabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian RhythmNCT03478306 · 2018-03-27
COMPLETEDCommon interventions
MelatoninDRUG3Cognitive behavioral therapy group for insomniaBEHAVIORAL1Conventional diabetic treatmentDRUG1Experimental: melatonin treatment groupDRUG1Folic acidDRUG1Group 1 (Doxorubicin group)DRUG1Group 2: Vitamin D groupDRUG1Group 3: melatonin groupDRUG1Melatonin 3 MGDRUG1Melatonin 4 mg TabletDRUG1PlaceboOTHER1Placebo comparator: placebo treatment groupDRUG1
Leading sponsors
Trial status mix
COMPLETED6
NOT_YET_RECRUITING1
Phase mix
NA5
PHASE31
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.